©The Author(s) 2015.
World J Cardiol. Oct 26, 2015; 7(10): 594-602
Published online Oct 26, 2015. doi: 10.4330/wjc.v7.i10.594
Published online Oct 26, 2015. doi: 10.4330/wjc.v7.i10.594
Table 1 Charge table (i€)
| Resource utilization | Mini | Mean | Max | Tariff |
| GP visit | 22 | |||
| Specialist visit (cardiologist) | 23 | |||
| Lab tests without markers of myocardial damage | 21 | |||
| Lab tests with markers of myocardial damage | 39 | |||
| ECG at rest | 14 | |||
| Stress test ECG | 77 | |||
| Stress test echocardiography | 165 | |||
| Myocardial scintigraphy | 409 | |||
| Coronary angiography | 1954 | |||
| Standard combination therapy (1 yr): aspirin + statin + ACE inhibitors | 364 | 743 | ||
| GTN (1 yr) | 39.4 | 73.2 | ||
| β-Blocker (1 yr) | 52.9 | 210.9 | ||
| Calcium Inhibitors (1 yr) | 87.5 | 311 | ||
| Hospitalization stay for PCI with BMS (1.6 stent) | 4074 | 4573 | ||
| Hospitalization stay for PCI with DES (1.6 stent) | 5284 | 5704 | ||
| Hospitalization stay for CABG surgery | 14065 | |||
| Hospitalization stay for a clinical failure | 2096 |
- Citation: Beresniak A, Caruba T, Sabatier B, Juillière Y, Dubourg O, Danchin N. Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World J Cardiol 2015; 7(10): 594-602
- URL: https://www.wjgnet.com/1949-8462/full/v7/i10/594.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i10.594